Gunderson, Andrew J.
Yamazaki, Tomoko
McCarty, Kayla
Fox, Nathaniel
Phillips, Michaela
Alice, Alejandro
Blair, Tiffany
Whiteford, Mark
O’Brien, David
Ahmad, Rehan
Kiely, Maria X.
Hayman, Amanda
Crocenzi, Todd
Gough, Michael J.
Crittenden, Marka R.
Young, Kristina H.
Funding for this research was provided by:
Collins Medical Trust
Sidney Kimmel Foundation
Providence Opportunity Fund
Article History
Received: 12 September 2019
Accepted: 10 March 2020
First Online: 9 April 2020
Competing interests
: LY2157299 and LY3200882 were used under MTA with Eli Lilly. The Earle A. Chiles Research Institute receives support from Bristol-Myers-Squibb. There is an ongoing clinical trial testing these reagents at the Earle A. Chiles Research Institute, which is partially funded by Eli Lilly through their ExIST program, for which K.H.Y. is the Principal Investigator. The remaining authors declare no competing interests.